REBLOZYL

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Turkey, United States

Active ingredients

The drug REBLOZYL contains one active pharmaceutical ingredient (API):

1 Luspatercept UNII AQK7UBA1LS - LUSPATERCEPT

Luspatercept, an erythroid maturation agent, is a recombinant fusion protein that binds selected transforming growth factor-β (TGF-β) superfamily ligands. By binding to specific endogenous ligands (e.g. GDF-11, activin B) luspatercept inhibits Smad2/3 signalling, resulting in erythroid maturation through differentiation of late-stage erythroid precursors (normoblasts) in the bone marrow. Read about Luspatercept

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
REBLOZYL Powder for solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC
REBLOZYL Powder for solution for injection / infusion	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03XA06		B Blood and blood forming organs → B03 Antianemic preparations → B03X Other antianemic preparations → B03XA Other antianemic preparations
Discover more medicines within B03XA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02505541, 02505568
Country: EE	Ravimiamet	Identifier(s): 1821912, 1821923
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1201452001, 1201452002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 473722, 598825
Country: FR	Base de données publique des médicaments	Identifier(s): 60175591, 62508169
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8784, 8785
Country: IT	Agenzia del Farmaco	Identifier(s): 048905018, 048905020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1090725, 1090726
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 203971, 203998
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100438911, 100438928
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67355001, W67356001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699726269406, 8699726269505
Country: US	FDA, National Drug Code	Identifier(s): 59572-711, 59572-775